| Data | Hora | Fonte | Título | Código | Companhia |
| 24/03/2009 | 18:30 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 24/03/2009 | 09:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 24/03/2009 | 09:00 | Business Wire | Allos Therapeutics Appoints David M. Stout to Its Board of Directors | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 20/03/2009 | 17:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/03/2009 | 09:00 | Business Wire | Allos Therapeutics’ Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Bladder Cancer by the Eu... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2009 | 18:00 | Business Wire | Allos Therapeutics Reports 2008 Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 26/02/2009 | 18:00 | Business Wire | Allos Therapeutics to Report 2008 Results on March 3, 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/02/2009 | 18:24 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 13/02/2009 | 19:49 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 09/12/2008 | 19:00 | Business Wire | Allos Therapeutics to Present at the RBC Capital Markets 2008 Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/12/2008 | 14:03 | Business Wire | Allos Therapeutics Announces Top Line Results from Pivotal Phase 2 PROPEL Trial of Pralatrexate in Patients with Relapsed or ... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 06/12/2008 | 15:30 | Business Wire | Two Pralatrexate Studies Presented at the 50th Annual Meeting of the American Society of Hematology | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/12/2008 | 11:00 | Business Wire | Allos Therapeutics to Host Analyst and Investor Briefing on Monday, December 8, 2008 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/12/2008 | 19:00 | Business Wire | U.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Follicular Lymphoma | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 24/11/2008 | 19:00 | Business Wire | U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell Lymphoma | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/11/2008 | 20:09 | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/11/2008 | 12:17 | Business Wire | Four Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of Hematology | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/11/2008 | 20:09 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/11/2008 | 19:00 | Business Wire | Allos Therapeutics Reports 2008 Third Quarter Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/11/2008 | 11:00 | Business Wire | Allos Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 30/10/2008 | 18:00 | Business Wire | Four Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of Hematology | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 29/10/2008 | 10:00 | Business Wire | Allos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 01/10/2008 | 09:00 | Business Wire | Allos Therapeutics to Present at the JMP Healthcare Focus Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 25/09/2008 | 10:05 | Edgar (US Regulatory) | Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/09/2008 | 18:06 | Edgar (US Regulatory) | Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/09/2008 | 09:00 | Business Wire | Allos Therapeutics to Present at the 3rd Annual Citi Biotech Day | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 28/08/2008 | 17:00 | Business Wire | Allos Therapeutics to Present at the NewsMakers in the Biotech Industry Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 25/08/2008 | 17:17 | Edgar (US Regulatory) | Allos Therapeutics Inc - Amended Annual Report (10-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/08/2008 | 18:30 | Edgar (US Regulatory) | Allos Therapeutics Inc - Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/08/2008 | 17:03 | Edgar (US Regulatory) | Allos Therapeutics Inc - Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |